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ArginineCell surface proteoglycans (PGs) appear to promote uptake of arginine-rich cell-penetrating peptides (CPPs),
but their exact functions are unclear. To address if there is speciﬁcity in the interactions of arginines and PGs
leading to improved internalization, we used ﬂow cytometry to examine uptake in relation to cell surface
binding for penetratin and two arginine/lysine substituted variants (PenArg and PenLys) in wildtype CHO-
K1 and PG-deﬁcient A745 cells. All peptides were more efﬁciently internalized into CHO-K1 than into
A745, but their cell surface binding was independent of cell type. Thus, PGs promote internalization of cation-
ic peptides, irrespective of the chemical nature of their positive charges. Uptake of each peptide was linearly
dependent on its cell surface binding, and afﬁnity is thus important for efﬁciency. However, the gradients of
these linear dependencies varied signiﬁcantly. Thus each peptide's ability to stimulate uptake once bound to
the cell surface is reliant on formation of speciﬁc uptake-promoting interactions. Heparin afﬁnity chromatog-
raphy and clustering experiments showed that penetratin and PenArg binding to sulfated sugars is stabilized
by hydrophobic interactions and result in clustering, whereas PenLys only interacts through electrostatic at-
traction. This may have implications for the molecular mechanisms behind arginine-speciﬁc uptake stimula-
tion as penetratin and PenArg are more efﬁciently internalized than PenLys upon interaction with PGs.
However, PenArg is also least affected by removal of PGs. This indicates that an increased arginine content
not only improve PG-dependent uptake but also that PenArg is more adaptable as it can use several portals
of entry into the cell.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cell-penetrating peptides (CPPs) have gained attention as drug de-
livery vectors due to their ability to efﬁciently enter cells and tomediate
uptake of macromolecular cargo [1]. Most CPPs enter cells predomi-
nantly via endocytosis, but despite extensive investigations ever since
the discovery of the ﬁrst CPP sequences [2–4], it is still not clear how
they enter cells [5–8]. There is little consensus as to which endocytic
pathways are most important, nor is it clear which cell surface compo-
nents CPPs preferentially interact with, if any, or to what extent uptake
requires that the peptide contains side-chains with speciﬁc chemical
properties. Several studies, including our own work, have indicated
that CPPs can trigger their own uptake by stimulating endocytosis
[9–12]. The mechanistic details of such a process are, however, not yet
understood. Cell surface proteoglycans (PGs), and especially those con-
taining the glycosaminoglycan heparan sulfate (HSPGs), have beenCHO-K1 clone pgsA-745, defec-
ein; CHO-K1, Chinese hamster
ycosaminoglycan; HEPES, 4-(2-
ran sulfate; PG, proteoglycan
+46 31 7723858.
rights reserved.suggested to be key players in CPP uptake and several studies have indi-
cated these moieties as essential for uptake [13–16]. The negative
charge of sulfated sugars provide (unspeciﬁc) electrostatic attraction
for cationic CPPs, but amore speciﬁc receptor-like role of proteoglycans
has also been suggested, where at least some CPPsmay promote uptake
by interacting selectively with proteoglycans containing particular
sulfation patterns [14,16–20]. However, recent results have also indicat-
ed that proteoglycans may have a less prominent role for CPP uptake
and CPP-mediated gene delivery [21,22], rendering their exact role
elusive.
While most CPPs are net positively charged, it has become clear
from several studies that CPPs with a large number of arginine resi-
dues are considerably more efﬁcient than their lysine-rich counter-
parts [9,23–27] despite the same net charge. This difference has
been attributed to the chemistry of the guanidinium head-group on
arginine residues that may allow formation of stable bidentate hydro-
gen bonds with polarizable oxo-anions such as sulfates or phosphates
[27]. Nevertheless, several well-described and functional CPPs seem
to gain sufﬁcient uptake efﬁciency solely from lysines (e.g. trans-
portan [28], MPG [29], Pep-1 [30]), adding further complexity to
this problem. A possible explanation to the generally superior uptake
efﬁciency of arginine-rich CPPs may be that their higher adsorption
afﬁnity for the cell surface increases the probability that they become
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possibility is that arginines form speciﬁc uptake-promoting interac-
tions with receptor-like components on the cell surface [14]. Al-
though a strong binding to the plasma membrane is for reasons of
statistics expected to increase internalization, earlier studies both sup-
port [21,31] and discard [32,33] such connections.We have recently de-
scribed linear correlations between the cell surface binding and cellular
internalization of penetratin and two variants. Our study showed that
the improved uptake of a penetratin analog with increased number of
arginines could be explained by its enhanced cell surface adsorption
[34]. In addition, we have also shown that the arginine-enriched pen-
etratin variant was better than its lysine-rich counterpart in stimulating
uptake by triggering macropinocytosis [9]. In the present study we fur-
ther explore factors that are important for CPP internalization. Our aim
was to address how cell surface proteoglycans inﬂuence cell surface as-
sociation and total cellular uptake, and to speciﬁcally explore whether
the composition of arginines and lysines in the peptide sequence can
contribute to preferential interactions with proteoglycan binding sites.
To this end we have compared the CPP penetratin to its two arginine-
or lysine-substituted variants denoted PenArg and PenLys in which all
positive residues are either arginines or lysines (see Table 1 for peptide
sequences). This triplet of CPPs was designed in our lab to speciﬁcally
explore how the primary amino acid sequence affects the functions of
CPPs and have previously been characterized both in terms of cellular
uptake [9,24] and interaction with model membranes [35–37]. PenArg
is a better CPP than penetratin whereas PenLys generally exhibits
poor uptake [9,24].
To examine how the relation between CPP cell surface binding and
uptake is affected by cell surface proteoglycans we have performed
comparative studies in wild-type and proteoglycan-deﬁcient Chinese
hamster ovary (CHO) cells. Peptide uptake and extracellularmembrane
binding was examined by ﬂow cytometry. Further, to explore differ-
ences between arginines and lysines in their interactions with sulfated
sugars, we examined their behavior in presence of heparin in vitro,
using heparin afﬁnity chromatography to assess their afﬁnity for
immobilized sugar moieties and ﬂuorescence quenching in combina-
tion with dynamic light scattering to explore their capacity to condense
heparin chains in solution. Identiﬁcation of the key factors, both
physico-chemical and biological, that determine uptake efﬁciency of
CPPs is central to future design and improvement of CPPs and for thede-
velopment of successful vectors for intracellular delivery.
2. Materials and methods
2.1. Cell culture
Chinese hamster ovary cells CHO-K1 and proteoglycan-deﬁcientmu-
tant CHO-pgsA745 cells (denoted A745) lacking the xylosyltransferase
needed for glycosaminoglycan (GAG) synthesis were cultured in
Ham's F12 medium supplemented with fetal bovine serum (10%) and
L-glutamine (2 mM) in humidiﬁed atmosphere at 37 °C and 5% CO2.
2.2. Peptide uptake
CHO-K1 and A745 cells were seeded in 96-well plates at a density
of 10,000 cells/well and cultured for 48 h to approximately 80%Table 1
Peptide sequences.
Peptide Sequencea
Penetratin RQIK IWFQ NRRM KWKK
PenArg RQIR IWFQ NRRM RWRR
PenLys KQIK IWFQ NKKM KWKK
a Arginines are marked in bold and lysines underlined.conﬂuence. Cells were washed with serum-free Ham's F12 medium
and carboxyﬂuorescein (CF) -labeled peptides (Innovagen, puri-
ty>80%) diluted in 100 μl serum-free medium were added to the
cells at indicated concentrations prior to incubation at 37 °C and 5%
CO2. The cells were thereafter rinsed twice with 20 mM HEPES/
150 mM NaCl, pH 7.4, supplemented with 100 μg/ml heparin
(Serva) in the ﬁrst washing step to remove externally bound peptide
[11,12]. The cells were detached by trypsination (10 min), followed
by immediate ﬂow cytometry analysis of uptake using a Guava
EasyCyte 8HT (Millipore). 5000 cells were collected and analyzed in
each sample. The peptide CF label was excited by a 488 nm laser
and emission was collected through a 525/30 nm ﬁlter. For quantiﬁ-
cation of cellular uptake, CF emission was gated for live cells based
on settings deﬁned by analyzing the side and forward scatter of live
untreated cells (Figs. S2 and S3). This procedure correlates well
with 7-AAD staining to exclude dead cells (Fig. S4). In our experi-
ments we wanted to avoid using secondary staining of the cells in
order to prevent cross-excitation or bleed-through that could distort
the quantitative data analysis. Intracellular ﬂuorescence intensity
(uptake) is reported as the mean cellular ﬂuorescence intensity.2.3. Membrane binding
Membrane binding was assessed using a protocol adapted from
Gump et al. [21]. Brieﬂy, cells were incubated with CF-labeled CPPs
at 4 °C to block endocytic uptake. This was followed by non-
enzymatic detachment of the cells to avoid that the bound peptide
becomes degraded and released from the cell surface prior to analy-
sis. To avoid cell internalization by direct membrane penetration
and for practical reasons incubation times were set to 15 min. The
incubation time does not affect the amount of bound peptide, since
this occurs instantaneously upon mixing the samples. Cells for
experiments (CHO-K1 and A745) were seeded in 96-well plates at
a density of 10,000 cells/well and cultured for 48 h to about 80%
conﬂuence. All solutions used in the cell surface binding experi-
ments were pre-cooled on ice to maintain experimental conditions
strictly at 4 °C. Cells were kept on ice for ~10 min prior to experi-
ment to inhibit endocytosis. They were thereafter washed with
serum-free Ham's F12 medium before addition of CF-labeled pep-
tides (1–15 μM) diluted in serum-free medium. The cells were incu-
bated for 15 min on ice, washed once in 20 mM HEPES/150 mM
NaCl, pH 7.4 and detached with non-enzymatic cell dissociation so-
lution prepared in phosphate buffered saline (Sigma) for 10 min, be-
fore immediate ﬂow cytometric analysis of membrane binding using a
Guava EasyCyte 8HT (Millipore), as previously described for peptide
uptake. The amount of peptide is expressed as mean intensity and rep-
resents peptide fraction that is resistant to washing and thus tightly
bound to the cell surface.2.4. Zeta potential
CHO-K1 and A745 cells were seeded at a density of ~15,000 cells/cm2
3 days prior to the experiment and cultured to ~80% conﬂuence. Cells
were washed and detached using a non-enzymatic cell dissociation solu-
tion (Sigma) for 10 min, followed by centrifugation (Heraeus Labofuge
200, 1500 g, 2 min) and re-suspension in ﬁltered 10 mM sodium phos-
phate/280 mM sucrose, pH 7.4 to an approximate cell concentration of
300,000 cells/ml. The zeta potential of each cell suspension was mea-
sured using a Zetasizer Nano-ZS and folded capillary cells with electrodes
(Malvern). Measurements were performed at 22 °C, with 25 runs for
each sample. The zeta potential was calculated from the electrophoretic
mobility using the Smoluchowski equation. Each measurement was re-
peated at least 10 times and mean and standard deviation were
calculated.
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Cells for confocal microscopy were seeded in glass-bottom dishes
(Ø 3 cm) at a density of 15,000 cells/cm2, 48 h prior to the experi-
ments. Cells were thereafter rinsed in serum-free medium, followed
by addition of the CF-labeled peptide (5 or 10 μM) diluted in 1 ml
serum-free medium, and incubation for 1 h at 37 °C. Prior to imaging,
the cellswerewashed again and freshmedia supplementedwith 7-AAD
(1 μg/ml, Life technologies) were added. To monitor intracellular local-
ization of the peptide a separate experimentwas performedwhere cells
were co-incubated with 50 nM LysoTracker® Red (Life technologies).
Images were acquired using a Leica TCS SP confocal system equipped
with a HCX PL APO CS 63× objective and the 488 nm laser line of an
Ar laser was used for excitation of the peptide CF label and the
543 nm laser of a He/Ne laser was used for excitation of 7-AAD.2.6. Heparin afﬁnity chromatography
The relative binding afﬁnity for heparin was assessed using hepa-
rin afﬁnity chromatography [38]. A 1 ml HiTrap Heparin HP column
(GE Healthcare) containing sepharose and immobilized heparin
from porcine intestinal mucosa (~10 mg/ml) was connected to a
Dionex Ultimate 3000 HPLC system. The column was equilibrated
with 50 mM sodium phosphate buffer pH 7.0 prior to injection of
CF-labeled peptide (100 μl of 150 μM penetratin, PenArg or PenLys).
The peptide was eluted using an isocratic step with phosphate buffer
(50 mM, pH 7.0) from 0 to 35 min, followed by a linear gradient of
NaCl (0–3 M) or GdnHCl (0–3 M) in phosphate buffer (50 mM, pH
7.0) from 35 to 65 min. The column was thereafter washed with
8 M urea for 30 min. A constant ﬂow rate of 0.5 ml/min was used
and peptide elution was monitored by absorbance at 495 nm.2.7. Fluorescence quenching
Binding of CF-labeled peptides to heparin in solution was moni-
tored by quenching of the CF label, as previously described for bind-
ing of CPPs to plasmid DNA [39]. 1 μM CF-peptide in 10 mM
phosphate/150 mMNaCl pH 7.4 was titrated with increasing amounts
of heparin in a quartz cuvette. After each heparin addition, the sample
was excited at 495 nm using a Cary Eclipse ﬂuorescence spectropho-
tometer (Varian) and emission was measured between 510 and
590 nm. The intensity at the emission maximum (I520) was normal-
ized against the intensity of free peptide in each sample. Each exper-
iment was repeated 3 times and mean and standard deviation were
calculated. The concentration of heparin was deﬁned on the basis of
disaccharide units, each having a molecular weight of 593 g/mol
and carrying 4 negative charges.2.8. Dynamic light scattering
The size of complexes formed by peptides and heparin was estimat-
ed from dynamic light scattering measured on a Zetasizer Nano-ZS
(Malvern), equippedwith a 633 nm laser and a backscatteringdetection
angle of 173°. All solutions were ﬁltered (0.45 μm) and measurements
were performed in a 70 μl micro cuvette (Brand) at 22 °C for 100 s. A
10 μM heparin solution prepared in 10 mM phosphate/150 mM NaCl
pH 7.4 was added to the cuvette and a small volume of peptide
(2–5 μl) was added, followed by immediate mixing by vortexing. Size
was measured directly after mixing and again after about 20 and
60min. A second-order cumulant analysis was used to obtain diffusion
coefﬁcients from the autocorrelation functions and the corresponding
hydrodynamic diameters were calculated using the Stokes–Einstein
equation. The size distributionswere calculated using the CONTIN algo-
rithm [40]. The presented sizes are weighted by intensity.3. Results
3.1. Cell surface proteoglycans increase uptake but not membrane
binding of penetratin
Fig. 1 shows the extracellular membrane association and the cellu-
lar uptake of CF-labeled penetratin in CHO-K1 and A745 cells as a
function of peptide concentration. Maximum uptake was obtained
after 1 h incubation (Fig. S1), and this incubation period was there-
fore used for all uptake experiments. The extent of cell membrane
binding (Fig. 1A) to the two cell types is very similar, indicating that
cell surface proteoglycans do not signiﬁcantly contribute to the over-
all cell surface absorption. Uptake on the other hand (Fig. 1B) is very
markedly reduced in A745 cells (the uptake of penetratin is approxi-
mately 3–4-fold higher in CHO-K1 cells). This is in agreement with
what has previously been observed for penetratin [33,41]. The
amount of internalized peptide increases linearly with the applied
peptide concentration in A745 whereas in CHO-K1 the amount of in-
tracellular peptide levels off at high peptide concentrations indicating
saturation. The cell surface binding also increases linearly with pep-
tide concentration but shows, in contrast to uptake, a slight upward
curvature at high concentrations in both cell types.
In an attempt to understand why the association of penetratin to
the surface of CHO-K1 and A745 cells is similar despite that the
A745 cell line is completely deﬁcient in cell surface proteoglycans
we decided to perform zeta potential measurements on cells in sus-
pension to estimate their surface charge. Cells were suspended in a
low salt buffer containing sucrose to match the intracellular osmolar-
ity. This prevented screening of charges from counter-ions and en-
abled the zeta potential to be adequately measured. The zeta
potential was determined from −22.2±2.5 mV for CHO-K1 and
−19.5±2.3 mV for A745 cells based on 10 repeated measurements
for each cell type (see Supplementary text and Supplementary Table
S1). This observation indicates that there is no signiﬁcant difference
in net negative charge between these two cell lines which may ex-
plain the similar binding that we observe. Similar results were also
obtained by comparing the electrophoretic mobility of the two cell
types using a microelectrophoresis setup (data not shown).
3.2. Inﬂuence of arginine and lysine residues on cell surface association
and uptake
Next, to explore how arginine and lysine residues contribute to
cell surface binding and subsequent cellular uptake we compared
the three peptides in their interactions with the CHO-K1 and the
A745 cells (Fig. 2). Panel A shows ﬂow cytometry histograms of the
cell count as a function of ﬂuorescence intensity for cells treated
with 5 μM peptide showing the distribution of ﬂuorescence intensi-
ties across the counted cells. Only live cells were included in the anal-
ysis of binding and uptake as described under Materials and methods
and depicted in Supplementary Figs. S2–S4. The bar diagrams in panel
B shows the mean cell ﬂuorescence intensity from 3 separate samples
and at two peptide concentrations (5 or 10 μM). First, this ﬁgure
shows that the arginine-dependence that we have previously ob-
served for both binding [34] and uptake [9] to CHO-K1 is present
also with PG-deﬁcient cells. Comparing each of the three peptides
across the two cell lines reveals that it is only PenArg that has margin-
ally higher afﬁnity for CHO-K1 than for A745 cells. This suggests that
presence of cell surface proteoglycans is only decisively important for
peptide binding, if the peptide has a high arginine content. On the
other hand, the differences in uptake between the two cell lines are
signiﬁcant for all three peptides.
To further illustrate the relationship between the amount of cell
surface-associated peptide and the total amount of internalized peptide,
we plotted the uptake as a function of cell surface association across
three concentrations (1, 5 and 10 μM) for each peptide in both cell
Fig. 1. Proteoglycans increase uptake of penetratin, but not cell surface binding. Cell surface binding (A) and cellular uptake (B) of penetratin was measured as a function of peptide
concentration. Cell surface binding was measured after incubation of cells at 4 °C to exclude endocytic uptake. The cells were detached with non-enzymatic cell dissociation solution
and washed in ice cold 20 mM HEPES/150 mM NaCl buffer pH 7.4. Cellular uptake was measured after 1 h incubation at 37 °C, followed by washing with 20 mM HEPES/150 mM
NaCl buffer pH 7.4 and heparin (100 μg/ml). Experiments were performed in both CHO-K1 (ﬁlled squares) and PG-deﬁcient A745 (open circles) cells. Binding and uptake was de-
termined as the mean ﬂuorescence of cells analyzed by ﬂow cytometry. The data points represent the mean (±S.D.) from 5 separate samples.
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amount of cell surface-associated peptide and it is therefore possible to
decouple the two events and separately compare internalization efﬁ-
ciency across the peptides or across cell types. For each peptide-cell
type combination we see that uptake is always linearly dependent on
cell surface binding, but the gradients are very different. Fig. 3 ﬁrst
shows that once peptide has bound to the cell surface uptake ismore ef-
ﬁcient in CHO-K1 (steeper gradients) than inA745 cells. Second,where-
as bound PenArg and bound penetratin appear to be equally efﬁciently
internalized in CHO-K1 cells, PenLys is not as efﬁcient. This points to
that penetratin and PenArg differ in uptake ability mainly due to differ-
ences in their cell surface afﬁnity but appear to be taken up by the same
mechanism, whereas the completely arginine-deﬁcient PenLys has in-
trinsically lower ability to internalize. In A745 there is an accentuated
and gradual difference in the gradient for the three peptides, indicating
that uptake capacity is more strongly dependent on the number of argi-
nines in the peptide sequence.
3.3. Intracellular distribution of internalized peptide
It has previously been reported that uptake pathways and hence
intracellular location of internalized CPPs may be dependent on the
presence of proteoglycans on the cell surface. For example, although
endocytosis is usually the primary internalization route, uptake via
direct membrane penetration has been reported for arginine-rich se-
quences, particularly in absence of proteoglycans [33,42]. We have
previously shown that uptake of penetratin, PenArg and PenLys in
CHO-K1 results in punctuate staining and that the peptide colocalizes
with markers for endocytosis [9]. To explore the intracellular localiza-
tion in A745 cells compared to CHO-K1 cells, we obtained confocal
microscopy images of live cells incubated with 5 or 10 μM of each of
the peptides (Fig. 4 and Fig. S5). Since we have seen that the degree
of uptake and hence intracellular ﬂuorescence intensity differs mark-
edly for the three peptides ([9,24] and Fig. 2), the image contrast and
detector settings were adjusted for best visualization of each peptide
and intensities in the images are therefore not comparable. At 5 μM
concentration (Fig. 4), all peptides show distinctly punctuate intracel-
lular staining which is characteristic for vesicular localization. We
have previously shown that this is consistent with endocytic uptake
[9]. Further, the vesicular localization in both cell lines was conﬁrmed
from the colocalization between peptide and LysoTracker® Red,
which stains acidic organelles including lysosomes (Fig. S6). None of
the peptides were toxic at 5 μM concentration as evident from the ab-
sence of 7-AAD staining. However, at 10 μM concentration (Fig. S5),we observed diffuse cytosolic staining for PenArg in combination
with clearly stained necrotic nuclei.
Although dead cells were not included in the quantitative analysis of
uptake and cell surface binding (see Supplementary text and Fig. S2),
we decided to further address the putative toxicity of PenArg. Flow cy-
tometry analysis revealed that only ~10–20% of the cells treated with
10 μM CF-labeled PenArg were excluded from the live cell cluster
(Fig. 5), compared to ~5% of untreated cells. Control experiments
using 7-AAD staining also in the ﬂow cytometry experiments showed
that a very signiﬁcant proportion (89%) of the cells that are excluded
by the depicted gate also stain positive for 7-AAD whereas only 1% of
the cells within the live cell gate were stained with 7-AAD (Fig. S4). Al-
together this indicates that whereas CF-labeled PenArg is moderately
toxic, this does not distort the quantitative analysis of uptake and bind-
ing. We also compared CF-labeled PenArg against unlabeled peptide
(Fig. S3). Interestingly it appears that it is only in presence of the label
that PenArg becomes more toxic than any of the other peptides
(which were all at the level of untreated controls).
3.4. Arginine-dependent heparin interactions
We further assessed how arginines and lysines affect the way that
penetratin peptides may interact with proteoglycans on the cell surface
by investigating in vitro their interaction with heparin, a heparan sulfate
analog [43]. We ﬁrst assessed their relative afﬁnity for immobilized hep-
arin, using heparin afﬁnity chromatography. In an initial set of experi-
ments we loaded each of the peptides onto a heparin afﬁnity column
and thereafter monitored the elution of peptide using a sodium chloride
(NaCl) gradient between 0 and 3 M(Fig. 6A, C). The peptides eluted from
the column in the order PenLys–penetratin–PenArg consistent with that
arginines have higher afﬁnity for sulfated sugars [44]. The peptides with
longer retention times on the column also displayed broader elution
peaks, suggesting that PenArg and penetratin can bind to the column
with a distribution of binding modes with variable afﬁnity. In addition,
the total peak area of the PenArg elution proﬁle (Fig. 6C) was only 30%
of that of penetratin and PenLys, showing that a major fraction of the
injected peptide binds so strongly to heparin that it cannot be displaced
by 3 M NaCl. Therefore we also tested to elute the peptides using a
guanidinium hydrochloride (GdnHCl) gradient (0–3M) (Fig. 6B, C).
Guanidinium has the same chemistry as the arginine head-group and
may therefore be considered as a more direct competitor for arginine
binding sites. In addition, GdnHCl is a chaotropic agent that is able to dis-
rupt not only ion-pairing, but also hydrogen bonding and hydrophobic
interactions which may contribute to the peptide-heparin interaction
Fig. 2. Arginines promote binding and uptake of penetratin in both CHO-K1 and A745 cells. (A) Representative ﬂow cytometry histograms showing binding at 4 °C (left) and uptake
at 37 °C (right) of 5 μM PenArg (blue), penetratin (red) and PenLys (green) in live CHO-K1 (top) and A745 (bottom) cells. (B) Cell membrane binding (left) and uptake (right) for
5 μM (top) or 10 μM (bottom) PenLys, penetratin and PenArg in CHO-K1 and A745 cells. The data points represent mean ﬂuorescence intensity (±S.D.) of gated live cells from 3
separate samples. Note the different scales in the four graphs.
Fig. 3. Cell uptake and binding show a linear correlation and are promoted by arginines.
Plotting uptake as a function of membrane binding for 1, 5 and 10 μM peptide indicates
the ability of the peptides to internalize into cells once bound to the membrane. The
lines represent linear regression of data.
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elution peaks are sharper. PenLys is virtually unaffected by the choice of
eluent, but the two arginine-containing peptides (penetratin and Pen-
Arg) have shorter retention times under elution with GdnHCl. Also, Pen-
Arg is completely replaced by 3 M GdnHCl.
Next we investigated heparin interaction by monitoring the ﬂuo-
rescence quenching of the N-terminal carboxyﬂuorescein (CF) upon
formation of peptide–heparin complexes in solution. Data were com-
plemented by dynamic light scattering (DLS) to characterize the size
distribution of the ensuing heparin–peptide complexes (Fig. 7). In
Fig. 7A, we show how the ﬂuorescence of the CF label on each of
the three peptides was gradually quenched when a 1 μM solution of
penetratin, PenArg or PenLys was titrated with heparin. The degree
of quenching is initially linear with increasing heparin concentration
but levels off and reaches a plateau value when the composition of
the sample is such that charge neutrality is reached. At charge neutrality
PenLys samples displayed ~40% of its initial CF ﬂuorescence intensity,
Fig. 4. Uptake of penetratin peptides is endocytic in both CHO-K1 and A745 cells. (A–F) Confocal images of live CHO-K1 (left) or CHO-A745 cells (right) incubated with 5 μM PenLys
(top), penetratin (middle) or PenArg (bottom) for 1 h at 37 °C and stained with dead cell marker 7-AAD (1 μg/ml). The punctuate staining indicates vesicular localization and up-
take via endocytosis. Cell toxicity could not be observed in any of the samples at 5 μM concentration. Contrast and gain have been optimized separately for each peptide. Scale
bars=25 μm.
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arginine-rich peptides.
The hydrodynamic diameters of peptide–heparin complexes pre-
pared with excess heparin (rb1) were determined from dynamic light
scattering and are shown in Fig. 7B. Complexes prepared with excess
of peptide (r>1) aggregated to such an extent that reliable data could
not be obtained due to the polydisperse nature of the samples and the
presence of large particulates (data not shown). At r=0.25, all three
peptides formed complexes with an apparent mean diameter of
~250 nm. These complexes were stable over time (1 h) and showed
no signs of further aggregation. At r=0.5, complexes between heparin
and PenLys remained small and compact whereas corresponding com-
plexes formed by penetratin or PenArg were metastable and continuedFig. 5. The percentage of cells excluded as dead based on light scattering (see Fig. S2) for CH
The dotted line represents the level for untreated control samples. The data represents meto increase in size during the ﬁrst hour of incubation. These larger ag-
gregates were highly polydisperse, as indicated by the error bars
which represent the width of the size distribution. Thus, arginines ap-
pear to promote clustering of several heparin chains, resulting in the
formation of larger aggregates (Fig. 7B).
4. Discussion
Mechanistic understanding of the physico-chemical interactions
and biological processes that determine CPP uptake is crucial for fur-
ther development of cell-penetrating peptides as adaptable and efﬁ-
cient delivery vectors. Uptake from the extracellular environment
into the cell can simplistically be considered as a two-step processO-K1 (A) and A745 (B) cells incubated with 1, 5, or 10 μM PenLys, penetratin or PenArg.
an (±SD) from 3 samples and 5000 cells where analyzed in each sample.
Fig. 6. Peptide afﬁnity for heparin increases with arginine content. Heparin sepharose afﬁnity chromatograms of CF-labeled penetratin peptides in 50 mM sodium phosphate buffer
pH 7, eluted with 0–3 M NaCl (A) or GdnHCl (B). The increasing salt gradient is shown as dashed lines. (C) Summary of the parameters retrieved from the chromatograms.
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(2) transport into the cell. The latter may occur either via endocytosis
or through direct plasma membrane penetration. It is expected that
an increased cell surface adsorption should increase the probability of a
CPP to become internalized, but we and others have also observed that
CPPs can trigger their own internalization by activating a biological re-
sponse such as stimulation of macropinocytosis [9–12], and such events
may be dependent on sequence-speciﬁc interactions. Proteoglycans areFig. 7. The capacity to bind and cluster heparin is arginine-dependent. (A) Binding of CF-l
520 nm. Small volumes of heparin were titrated into 1 ml 1 μM peptide solution in 10 mM
at the top. The data represents mean and standard deviation from 3 separate experime
mixed at charge ratios r=0.25 (left) and r=0.5 (right). A small volume of peptide was ad
of the formed complexes were measured at different time-points. The data represents thecommonly suggested as the primary non-lipid CPP binders on the cell
surface and receptor-like CPP-proteoglycan interactions have been de-
scribed [20]. On the other hand, recent studies have indicated that pro-
teoglycans may in fact be less important for CPP uptake than what was
previously thought [21,22].We thereforewanted to explore themolecu-
lar prerequisites for uptake-promoting interactions and to address
whether these are primarily related to the afﬁnity of a CPP for the cell
surface or whether arginines or lysines will confer additional speciﬁcity.abeled peptides to heparin in solution, monitored by quenching of the CF emission at
sodium phosphate/150 mM NaCl pH 7.4. Corresponding charge ratio (+/−) is shown
nts. (B) Dynamic light scattering measurements of penetratin peptides and heparin
ded to 10 μM heparin in 10 mM sodium phosphate/150 mM NaCl pH 7.4 and the size
mean size by intensity and the error bars the size distribution width.
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We show that presence of cell surface proteoglycans (PGs) in-
crease the total cellular uptake of penetratin and its arginine and ly-
sine enriched variants (Figs. 1B, 2B). This is in line with and extends
previous ﬁndings presented in the literature [13–16,33,41]. The supe-
rior uptake in presence of PGs is consistent with the idea that PGs
may serve as non-chiral receptors for stimulation of uptake via for
example macropinocytosis [20], and suggests that penetratin can
form speciﬁc uptake-triggering interactions with these cell surface
moieties. In fact, the C-terminal domain of penetratin contains a con-
sensus motif that is found in heparin-binding proteins [43], which
could potentially be involved in forming speciﬁc interactions. Yet, in
agreement with other studies [33,41], we ﬁnd that the cell surface ad-
sorption afﬁnities of penetratin are the same for both wild type CHO-
K1 and the A745 cell line despite the lack of proteoglycans in the lat-
ter (Fig. 1A). This is supported by our observation that the two cell
types do not differ in their zeta potentials indicating that the net neg-
ative surface charges of CHO-K1 and A745 cells are the same. PGs thus
appear to contribute only marginally to the total negative cell surface
charge despite their strong uptake promoting function. Alternatively
PG charges are to a larger extent buried in the cell glycocalyx where
they would contribute less to the electrophoretic mobility. The simi-
larity in peptide afﬁnity for the two cell lines suggest that it is mainly
unspeciﬁc electrostatic attraction that determines their binding.
Although absence of PGs altered the uptake levels we could
not see any effects on vesicular intracellular localizations (Figs. 4,
S5–S6). Thus, we ﬁnd that all three peptides are preferentially inter-
nalized by endocytosis in both CHO-K1 and A745, disputing a previ-
ous suggestion that absence of PGs will lead to direct membrane
penetration for penetratin [33,42]. On the other hand, with 10 μM
PenArg we found weak cytoplasmic peptide staining but this was al-
ways accompanied by an altered cell morphology and with 7-AAD
staining of necrotic cell nuclei (Fig. S5). We therefore ﬁnd it likely
that the cytoplasmic staining is a result of that the dead cells lose
membrane integrity rather than that the peptide can efﬁciently
cross the membrane of the living cells. It should here be pointed out
that only 10–20% of the cells treated with 10 μM PenArg were dead
in the ﬂow cytometry experiments (Fig. 5) and that dead cells were
always excluded from the quantitative analysis of uptake and binding
(Figs. S2, S4). Interestingly we also found that PenArg is only cytotox-
ic in its CF-labeled form. CF is negatively charged and therefore
reduces the net negative charge of the peptide. At the same time it intro-
duces signiﬁcant hydrophobicity. Thus, we show that carboxyﬂuorescein
at least together with certain peptide sequences (probably arginine rich
in light of our results) may confer toxicity.4.2. The role of arginines in uptake of cell surface associated peptide
Penetratin contains three arginines and four lysines. Our present
work together with previous studies from our lab have shown that
the balance between these residues inﬂuence both the peptide's abil-
ity to bind to the cell surface [34,35,37] and its uptake efﬁciency
[9,24]. Arginines clearly contribute to cell surface afﬁnity, but our re-
sults show that this is not the only explanation to its superior uptake.
In fact, we show that increased arginine content also results in better
capacity to stimulate uptake once the peptide is bound. To be able to
address the contributions from cell surface binding and uptake stim-
ulation separately we plotted uptake as a function of binding at differ-
ent concentrations (Fig. 3). We found that cellular uptake is always
linearly dependent on the amount of peptide that is bound to the
cell surface. This is in accord with classical descriptions of adsorptive
endocytosis [31]. However, the gradient of this linear relation is
different for each peptide-cell type combination indicating speciﬁc
effects of both peptide sequence and of proteoglycans.Interestingly, comparing the uptake/binding dependence of the
peptides in CHO-K1 reveals that there is no difference in the extent
to which the cells internalize penetratin or PenArg, once they are
bound to the cell surface. On the other hand, bound PenLys cannot
be taken up as efﬁciently, as indicated by the less steep slope. In
A745 there is a much more evident difference among the peptides.
For a given amount of bound peptide, PenArg is more efﬁciently inter-
nalized via non-PG mediated uptake pathways than both penetratin
and PenLys. This points to that arginines can mediate some internaliza-
tion pathways that are not available to lysines, indicating sequence-
speciﬁcity in at least one non-PG interaction.
Comparing instead each peptide across the two cell lines, the gra-
dient of the uptake/binding dependence is lower in A745 compared
with wild-type for both penetratin and PenLys, whereas the differ-
ence for PenArg is actually smaller. This would mean that PenArg is
the peptide that is least affected by removal of proteoglycans and
PenArg thus appears to be the most versatile peptide in this study, ca-
pable of using several different portals of entry into the cell.
4.3. Intermolecular forces involved in penetratin binding to sulfated
sugars
Penetratin and PenArg are equally well internalized into CHO-K1
cells once bound, whereas arginine-deﬁcient PenLys is less efﬁcient.
This observation is well reﬂected in the longer retention times for
the arginine-containing peptides on the heparin afﬁnity column and
is consistent with the stronger binding between arginines and sulfat-
ed sugars that has been reported for heptaarginines and heptalysines
as well as arginine- and lysine-substituted heparin-binding peptides
[44]. Interestingly, PenArg could only be completely released from
the column by chaotropic GdnHCl and for both PenArg and pen-
etratin, but not PenLys, retention times were shorter with GdnHCl
compared to NaCl. This shows that arginine binding to sulfated sugars
is stabilized by a combination of electrostatic attraction, hydrogen
bonding, and hydrophobic interaction whereas lysine interactions
are more strictly electrostatic. These attributes of course explain
why the bidentate hydrogen bonding between arginine and sulfate
provide arginine-containing CPPs with superior cell surface afﬁnity
compared to their lysine counterparts [27,47]. However, a more in-
triguing conclusion of our observations is that the hydrophobic inter-
actions with PGs may be important for triggering uptake. Indeed, this
could explain why PenLys, which cannot form such interactions, are
less efﬁciently internalized into CHO-K1, even once cell surface afﬁn-
ity has been taken into account.
The heparin chromatography data also provided support for bind-
ing cooperativity in the interaction between arginine-containing pep-
tides and sulfated sugars. This is consistent with that PenArg and
penetratin could promote clustering of heparin chains into large par-
ticulates (Fig. 7B). Altogether our results therefore support the idea
that CPP-promoted clustering of several heparan sulfate chains on
the cell surface can be critical for initiation of down-stream signaling
events that trigger endocytosis [20]. This clustering ability may be
unique to arginines. However, our data disputes that this would be
the only arginine-dependent pathway into the cell as we observe
(in fact even more pronounced) differences in A745 cells.
4.4. Uptake via binding to alternative cell surface sites
The fact that the overall adsorption afﬁnity is not particularly dif-
ferent between the cell lines implies that PGs cannot be the primary
or not even the most common CPP binding sites on the cell surface.
As discussed above, we conﬁrmed this conclusion by showing that
CHO-K1 and A745 cells have similar zeta potentials. In light of this,
it is interesting to consider other negatively charged putative binding
sites that may contribute to peptide internalization. Alternative bind-
ing could involve for example complexation with negatively charged
2677H.L. Åmand et al. / Biochimica et Biophysica Acta 1818 (2012) 2669–2678lipids [27,46] presented on the surface of cells that are in early apoptosis
[47] or binding tomembrane glycoproteins and glycosphingolipids con-
taining sugars such as sialic acids. The latter are amore abundant source
of negative charge on the cell surface than PGs. Sialic acid monosaccha-
rides carry negatively charged carboxyl groups that typically occur at
the distal end of sugar chains where they serve as receptors for several
extrinsic and intrinsic proteins [48,49]. Our results suggest that there is
a marked arginine-dependence in both the afﬁnity for such non-PG
binding sites and in the stimulation of uptake once the peptides are
bound. These alternative binding sites would deserve even further
attention.
4.5. Conclusions
This study adds to the growing evidence that cell surface PGs pro-
mote cellular internalization of positively charged CPPs, particularly
for those containing arginines. Moreover, we show that whereas the
uptake of a particular CPP correlates directly with its cell surface ad-
sorption, CPPs can also have very different capacities to stimulate up-
take once they are bound to the cell surface. This may have important
implications for CPP design as it is not only the cell surface adsorption
afﬁnity, but to a large extent the speciﬁcity in their interaction that
determines internalization.
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